WW domain is one in the peptidyl-prolyl isomerase (PPIase) Pin1. Pin1 specifically isomerizes the pSer/Thr-Pro bond (8) (9) (10) . Pin1 is essential for mitotic progression in human and yeast cells (11) (12) (13) , and is required for the DNA replication checkpoint in Xenopus extracts (14) . Pin1 substrates are a defined subset of phosphorylated proteins, including many MPM-2 antigens (8, 13, (15) (16) (17) (18) (19) (20) .
Pin1-catalyzed prolyl isomerization regulates the conformation and function of phosphoproteins (15, 17) and also facilitates dephosphorylation because of the conformational specificity of some phosphatases (12, 15, 17) . Thus, Pin1-dependent peptide bond isomerization is a critical postphosphorylation regulatory mechanism, allowing cells to turn phosphoprotein function on or off with high efficiency and specificity (12). However, given a consist level of Pin1 during the cell cycle (14, 15) , Pin1 is likely regulated by a post-translational modification.
The first and essential step in Pin1-dependent regulation of targets is the substrate binding activity mediated by its WW domain (17) . The WW domain functions as a pSer/Thr-Pro-binding module, with the binding pocket including the side chains of S16, R17, Y23 and W34 (3, 4) . Interestingly, Ser16 is located at the center of the shadow pSer/Thr-Pro-binding pocket. Here we show an essential role for phosphorylation of Ser16 in regulation of the WW domain pSer/Thrbinding activity and subsequent Pin1 cell cycle function.
Results and Discussion

WW Domain Phosphorylation Regulates its Ability to Mediate the Pin1 Substrate
Interactions in vitro
To examine whether phosphorylation affects the binding activity of the Pin1 WW domain, we first incubated Pin1 and its WW domain with purified kinases and found that PKA and PKC readily phosphorylated Pin1 and its WW domain (Fig. 1A , data not shown). Furthermore, Phosphorylation by PKA, but not PKC, completely abolished the interactions between Pin1 or its WW domain and MPM2 antigens (Fig. 1B ). Even after Pin1 had already bound to MPM-2 antigens, PKA treatments resulted in disassociation of Pin1 from MPM-2 antigens (Fig. 1C) . These results are significant because Ser16 of Pin1 is conserved and located in a consensus phosphorylation site for PKA (Fig. by guest on July 15, 2017 http://www.jbc.org/ Downloaded from 1A) (21) . These results indicate that phosphorylation of Pin1 at the WW domain, possibly on Ser16, can prevent Pin1 from interacting with its substrates.
To examine the importance of Ser16 of Pin1, it was mutated to Glu to mimic pSer and the mutant Pin1 S16E failed to bind mitotic phosphoproteins (Fig. 1D) . Similar effects were observed on the binding to Pintide (WFYpSFLE) (Fig. 1E) , an optimal peptide ligand for the Pin1 WW domain (8) , as determined by the fluorescence polarization assay (4) . As a control, a Glu substitution was made at Ser18 outside the binding pocket (9) and this mutation had no effect (Fig. 1B, D, E) . These results confirm that the S16E mutation completely abolishes the ability of the Pin1 WW domain to bind mitotic phosphoproteins and suggests that phosphorylation of Ser16 may function as a regulatory phosphorylation site.
Since PKA also phosphorylated Pin1 on at least one other site, as suggested by reduced phosphorylation of Ser16 mutants ( Fig. 1F ) and confirmed by phosphopeptide analysis (Fig. 2D , see below), we examined whether Ser16 is the only phosphorylation site that regulates Pin1 binding activity. To address this question, Ser16 was substituted with Ala. Like Pin1, Pin1 S16A bound to most, if not all, Pin1 substrates (Fig. 1B, D) , and to Pintide with a compatible binding affinity (Fig.   1E ). Furthermore, Pin1 S16A binding to phosphoproteins was not affected by PKA (Fig. 1B) , although Pin1 S16A was still phosphorylated on another site by PKA (Fig. 1F, 2C ). These results indicate that Ser16 phosphorylation is both essential and sufficient to regulate the ability of the WW domain to mediate phosphorylation-dependent ligand recognition.
WW Domain Phosphorylation Regulates its Ability to Mediate the Pin1 Substrate
Interaction and subcellular Location in vivo
To examine whether Pin1 is phosphorylated in cells and whether Pin1 phosphorylation is regulated during the cell cycle, we first performed in vivo 32 P-labeling experiments and showed that Pin1 was phosphorylated in growing HeLa cells, exhibiting as a single slow migrating species on SDS-gels.
Moreover, this species was dephosphorylated upon mitotic arrest, with the appearance of a faster migrating species ( Fig. 2A) . To determine the kinetics of Pin1 dephosphorylation during the cell cycle, lysates were collected at various times after release from G1/S arrest and separated on modified SDS-gels, followed by immunoblotting with Pin1 antibodies. As shown (Shen et al., 1998 ), Pin1 levels did not significantly fluctuate, but two different forms of Pin1 were detected (Fig.   2B ). The appearance of the faster migrating form of Pin1 was cell cycle-dependent, appearing mainly when cells progressed through mitosis or were arrested at mitosis, but mostly disappearing as cells exited from mitosis (Fig. 2B) . Phosphatase treatment converted the slow migrating form of Pin1 into the faster migrating one (data not shown). Both 32 P-labeling and mobility shift results
show that the appearance of the faster migrating species of Pin1 represents dephosphorylation of Pin1. Thus, Pin1 is phosphorylated in a cell cycle-regulated manner. Interestingly, the dephosphorylated form of Pin1 is detected in breast cancer tissues overexpressing Pin1 (22) .
Next, to examine whether Ser16 of Pin1 is phosphorylated in vivo, we transfected HeLa cells with HA-Pin1, Pin1 S16A or Pin1 S16E and labeled them with 32 P. Transfected Pin1 proteins were expressed at rather high levels in cells (>10 fold higher than endogenous Pin1) and the majority of these expressed proteins was not phosphorylated in cells, as determined by comparing the expression levels and the 32 P-labeled intensity with those of endogenous protein ( Fig. 2A , C, data not shown). This is likely due to high levels of expression in transient transfection and the limitation of the kinase activity responsible for Pin1 phosphorylation. In any case, a fraction of proteins was phosphorylated to allow us to analyze the phosphorylation site. Although Pin1 and its mutant proteins were expressed at similar levels, the intensity of 32 P-labeled Pin1 S16A or Pin1 S16E was slightly less than half of that observed in wild type Pin1 (Fig. 2C , data not shown). To confirm that Ser16 is indeed phosphorylated in vivo, 32 P-labeled proteins were extracted from the gels and digested with trypsin, followed by 2-dimensional phosphopeptide mapping (23) . As a control, we used Pin1 and Pin1 S16A phosphorylated with PKA in vitro (Fig. 1F ). PKA phosphorylated Pin1 and produced 5 major tryptic peptides, No1-5, and a minor species (Fig. 2D ). Interestingly, in vivo labeled Pin1 also produced the same five tryptic peptides, as indicated by mixing experiments, and phosphorylation of peptide No1 was not affected by the S16A mutation either in vivo or in vitro ( Expressed Pin1 has been shown to be localized at a nuclear substructure called the nuclear speckle during interphase (11) , likely due to that most of the expressed protein is not phosphorylated and therefore can interact with phosphoproteins at this location, including phosphorylated CTD (13, 19, 20 and its WW domain in vitro (Fig. 1A) . Furthermore, PKA phosphorylated on the same site as the in vivo phosphorylation sites (Fig. 2D) . The S16A mutation abolished the ability of PKA to phosphorylate Pin1 on Ser16 (Fig. 2D) , and the ability of PKA to regulate Pin1 binding to phosphorylated targets (Fig. 1B) . If PKA can phosphorylates Ser16 in vivo, PKA activation would disrupt the Pin1 WW domain binding to its binding proteins in the nuclear speckle and abolish its nuclear speckle localization. To examine this possibility, we transfected HeLa cells with a red RFPPin1 construct and treated them with forskolin and the inactive forskolin analog 1,9-dideoxylforskolin (25) . Upon forskolin treatment, the translocation of RFP-Pin1 occurred immediately and reached a maximum after 30 min in the majority of cells (Fig. 3B ). The relocation of Pin1 back to the nuclear speckle also occurred at a similar rate for most cells (Fig. 3B ). In contrast, this Pin1 relocation activity was not observed with 1,9-dideoxyl-Forskolin (Fig. 3C) . Furthermore, the localization of Pin1 S16A and Pin1 S16E was not affected by forskolin treatment (Fig. 3C , data not shown). These results demonstrate shown that activation of PKA abolishes the preferential localization of Pin1 to the nuclear speckle. In addition, PKA-mediated phosphorylation can lead to dissociation of Pin1 from its substrates in vitro (Fig. 1C) . To confirm that the Forskolin treatment stimulates phosphorylation of a significant fraction of the Pin1 population at Ser16 and that the kinetics of phosphorylation correlate with the kinetics of dispersal and then re-speckling, we compared in vivo phosphorylation of GFP-WW and GFP-WW S16E at different after Forskolin treatment. A significant fraction of GFP-WW domain, but not GFP-WW S16E , was phosphorylated at time 0 (Fig. 3D) , consistent with phosphorylation of Pin1 on Ser16. Importantly, Foskolin treatment increased phosphorylation of GFP-WW domain in a time-dependent manner, reaching the maximal level between 1.0 and 2.0 hr and then decreasing (Fig. 3D) . Interestingly, the kinetics of phosphorylation was similar to that of dispersal and then re-speckling. lowest levels at the G2/M transition, and the highest levels upon exit from mitosis (26, 27) .
WW Domain S16A, but not S16E Mutation Affects the Cell Cycle in vivo
Given the essential role of WW domain phosphorylation in abrogating Pin1 substrate interactions and its subcellular localization, we would expect that the S16A mutations would affect Pin1 function. To examine this possibility, we determined the effects of transfected GFP-WW domain or -Pin1 proteins on cell and nuclear morphology in HeLa cells because depletion of Pin1 in these cells induces mitotic block and apoptosis (11) . Expression of either vector GFP or the WW S16E domain had no significant effect on the overall cell or nuclear morphology (Fig. 4) . In contrast, a significant number of cells expressing WW S16A were rounded up and their chromatin condensed at 24 hr after transfection. By 36 hr, 54% of the cells expressing the GFP-WW S16A and 34% of the cells expressing the GFP-WW domain were rounded up, with condensed chromatin and/or fragmented nuclei, which were often present in two dividing mitotic cells (Fig. 4A, B) , similar to phenotypes induced by depletion of Pin1 (11). These results suggest that WW domain and WW S16A , but not WW S16E , induce mitotic block and apoptosis.
To examine whether that WW S16A induced apoptosis from interphase or mitosis, we used MPM-2 antibodies to mitosis-specific phosphoproteins in apoptotic cells. WW S16A -, but not WW S16E -expressing cells were strongly stained with MPM-2 after 24 hr transfection and this staining was observed in apoptotic cells even at 36 hr, as shown in Fig. 4B . Moreover, GFP-WW S16A and MPM-2 antigens were co-localized at certain substructures in mitotic and apoptotic cells (Fig. 4B) , supporting the notion that the WW domain indeed binds the MPM-2 antigens in vivo. The nuclear lamina in WW S16A -expressing cells was also dissembled (data not shown). These results indicate that expression of WW S16A or WW domain induces mitotic block and apoptosis. In addition, after 36 hr transfection, cells with two nuclei, or sometimes even 4 nuclei were observed in the cells expressing the WW S16A , but not the WW S16E mutant (Fig. 4C) .
To confirm the morphological phenotypes, we used flow cytometry to analyze the effects of WW domain mutants on the cell cycle profile. Expression of the GFP vector or WW S16E had no detectable effect (Fig. 4D) . However, expression of either WW S16A or WW domain resulted in a significant increase in cells with 4n DNA content and with the sub-G1 DNA content (Fig. 4D) , supporting that WW S16A or WW domain induces mitotic block and apoptosis. Furthermore, 16%
of WW S16A -and 13% of WW-expressing cells contained the 8n DNA content (Fig. 4D) , confirming the appearance of multinucleated cells (Fig. 4C) . Moreover, WW S16A was slightly more effective than WW domain at 36 h after transfection (Fig. 4D ). These differences correlate with the observation that WW domain, but not WW S16A , may be subjected to endogenous regulation by phosphorylation. These results indicate that expression of WW S16A or WW domain induces mitotic block and apoptosis and increases multinucleated cells.
To insure that similar phenotypes are also observed in full-length Pin1, Pin1 and its point mutants Pin1 S16A and Pin1 S16E were transfected into cells. As compared with GFP, expression of Pin1 resulted in a small decrease in the mitotic index and a significant increase in cells with the 4n DNA content at 36 h, but there were no cells with the sub-G1 or 8n DNA content (Fig. 4E) . These results are consistent with the idea that overexpression of Pin1 delays the G2/M transition in HeLa cells or Xenopus extracts (11, 15, 16) . As compared with the WW domain alone, the failure of overexpressed Pin1 to induce mitotic block and apoptosis is likely due to the fact that Pin1's PPIase domain can act on Pin1 substrates. Importantly, although Pin1 S16E had no effect, GFPPin1 S16A induced mitotic block and apoptosis and formation of multinucleated cells with the 8n DNA content (Fig. 4E) , the same phenotype as those induced by WW S16A (Fig. 4D ). These results demonstrate that expression of the S16A Pin1 mutant either as the isolated WW domain or as fulllength Pin1 results in the same phenotypes.
Based on the crystal structure (7), Ser16 phosphorylation would allow phosphate group to interact with the side chain of R17 and Y23 and the backbone amide of R17 of the WW domain, thus blocking its ability to interact with pSer/Thr-Pro motifs in target proteins. In the S16E mutant, some of these latter WW domains may also be subjected to phosphorylation-mediated in vivo regulation. Significantly, SH2 domain Tyr phosphorylation also modulates its binding specificity (28, 29) . Therefore, we suspect that phosphorylation may be a general mechanism for controlling the function of at least some pSer/Thr phosphoprotein-binding modules.
Materials and Methods
Interaction of Pin1 mutants and MPM-2 antigens or phosphopeptides
GST fusion proteins containing Pin1 and various mutants were expressed and purified, and their ability to bind mitotic phosphoproteins from HeLa cells assayed, as described (8, 15) . Peptide binding was measured with the fluorescence polarization assay, as described (4).
Localization analysis of GFP-Pin1 and its mutant proteins
To produce green (GFP) or red fluorescence protein (RFP) fusion proteins with Pin1 or its mutants, the coding region of Pin1 or its mutants was subcloned into pEGFP-C1 or pERFP-N1
(Clontech), respectively. HeLa cells were transfected with pGFP-or pRFP-Pin1 or its mutants using superfect (Qiagen). After 6 to 24 hours, cells were fixed and examined under a fluorescence microscope (Nikon), as described (30) .
In vivo and in vitro phosphorylation of Pin1
To detect Pin1 phosphorylation in vivo, HeLa cells were labeled with 32 P orthophosphate and Pin1
was immunoprecicipitated with anti-Pin1 antibodies, followed by SDS-PAGE and autoradiography (4) . To compare Pin1's and its mutant's phosphorylation level, HeLa cells were transfected by HAPin1 or its mutants and labeled with 32 P orthophosphate, followed by immunoprecipitation using anti-HA antibody and SDS-PAGE. 32 P-labeled Pin1 proteins were extracted and digested with trypsin, followed by two-dimensional chromatography (23) . In vitro phosphorylation of Pin1 and its mutants were carried out, as described (4). To detect the mobility shift of Pin1 during the cell cycle, HeLa cells were arrested at the G1/S boundary, and released to enter the cell cycle, as described (15, 30) . Cell lysates were subjected to low bis SDS-PAGE to allow the detection of a small mobility shift, followed by immunoblot with anti-Pin1 or anti-cyclin B1 antibodies.
Analysis of cell cycle phenotypes
HeLa cells were transfected with various Pin1 constructs and cells were observed live or after fixation. The index of apoptotic cells was determined after DAPI staining and cells with highly condensed or fragmented DNA, or with micronuclei were scored as positive (11, 30) . 
